The plasma quinidine curves obtained by the oral and intramuscular routes of administration of 0.6 Gm. quinidine sulfate and 0.65 Gm. quinidine lactate, respectively, were generally similar. Maximal concentration, averaging 3.2 mg. per liter in the former group occurred from one-half hour to four hours after administration, and in the latter averaged 2.6 mg. per liter in one to three hours. Significant quantity of quinidine remained at eight hours, and small amounts at twentyfour hours. Rectal administration of 0.6 Gm. quinidine sulfate resulted in lower concentrations, the maximum averaging 0.89 mg. per liter. The chief value of intramuscular quinidine therapy appears to be the avoidance of gastrointestinal irritation, but hypotensive reactions were relatively frequent in the small series of patients studied.
SEVERAL groups of workers have reported the plasma quinidine concentrations after the oral administration of single doses of quinidine sulfate. '-4 In the present study, quinidine sulfate was given orally and rectally and quinidine lactate intramuscularly, and the pattern of quinidine concentration was determined at various times after administration.
The plasma quinidine content was determined by the fluorometric method described by Brodie and Udenfriend in 1943.5 The procedure consists of adding a fixed volume of metaphosphoric acid to a diluted plasma specimen to obtain a protein-free filtrate, and then of determining the concentration of quinidine in the filtrate by means of a photofluorometer.
The patients (table 1) were chosen at random, but with care to exclude anyone with gastrointestinal or urinary tract disturbances. Plasma samples were obtained prior to the administration of the quinidine and at regular intervals thereafter, usually according to the following schedule: at fifteen, thirty, and sixty minutes, and at two, four, eight, twelve, and twenty-four hours.
The observations in 6 patients using single 1) showed maximum plasma quinidine contents varying from 2.9 to 3.7 mg. per liter with an average content of 3.2 mg.; these peak concentrations occurred from one-half to four and one-quarter hours after administration of the drug, or in an average time of two and onequarter hours. The fall in plasma content of quinidine (table 2) occurred at about the following rates: 55 to 96 per cent of the maximum concentration remained in four hours, 42 to 73 per cent remained in eight hours, and 0 to 22 per cent was still present in twenty-four hours.
The above findings are approximately the same as those observed by other investigators. Wegria and Boyle1 gave 4 patients 0.8 Gm. and 2 patients 0.6 Gm. of quinidine sulfate orally and observed maximum plasma concentrations ranging from approximately 2.0 to 3.0 mg. per liter in from one to four hours. Delevett and Poindexter2 administered 1.0 Gm. of quinidine to 20 patients and noted maximum concentrations varying from 1.48 to 4.32 mg. per liter in from three-quarters to four hours. Hiatt3 gave 10.0 mg. of quinidine per kilogram of body weight (approximately 0.70 Gm. to a patient weighing 150 pounds) and recorded maximum concentrations of from 2.0 to 3.0 mg. per liter in two to three hours in several patients. Linenthal, Ulick, and Patterson4 noted average maximum quinidine concentrations of 2.0 mg. per liter occurring in from one to three hours after doses of 0.6 Gm. of quinidine were administered. Though the quinidine 65  43  26  64  63  59  73  66  65  78  59  70  67  27  59  51 Height (feetinches) 5-5 5-8 5-6 5-7 5-2 5-5 5-0 5-6 5-61 5-0 5-12 Six patients were given quinidine lactate,* intramuscularly. Five of these are illustrated in figure 2. Of this group, 2 patients received 0.13 Gm. and showed maximum plasma contents of 0.85 and 0.43 mg. per liter in three and three-quarters and three-quarters hours, respec- tients who received quinidine orally. The percentage fall from maximum concentrations (table 2) was less than for the orally administered quinidine; 71 to 94 per cent remained at four hours, 45 to 83 per cent at eight, and 10 to 28 per cent at twenty-four hours. Assuming that these figures are significant, it is possible that the delav in excretion could be due to fixation of quinidine by skeletal muscle, which has been demonstrated by Wegria and Boylet to fix about one-third to one-half the quantity of quinidine fixed by cardiac muscle. There was more variation of the maximum quinidine plasma concentrations among those receiving the drug intramuscularly than among those receiving it orally. In 4 patients who were given 0.6 Gm. of quinidine sulfate rectally ( fig. 3) , the maximum plasma quinidine contents varied from 0.51 to 1.19 mg. per liter, an average of 0.89 mg., with peaks at one and one-half to six hours in an average time of three and one-quarter hours. About 40 to 80 per cent of the maximum concentration was present in eight hours, only a trace remained at twelve hours, and none was detected at twenty-four hours after the time of administration (table 2) .
There was no consistent correlation between the weights of patients and the plasma quinidine concentrations.
SUMMARY AND CONCLUSIONS 1. The plasma quinidine concentrations observed when the drug was given by three routes, orally, intramuscularly, and rectally, were compared. The maximum concentrations following the administration by the three routes of approximately 0.60 Gm. of quinidine averaged, respectively, 3.2, 2.68, and 0.89 mg. per liter in an average time of two and one-quarter, two and one-third, and three and one-quarter hours.
2. The intramuscular route, resulting in approximately the same plasma concentration curves as when the drug is given by the oral route, would seem to be valuable chiefly when quinidine cannot be given orally because of certain patients' intolerance to the oral administration as evidenced by nausea or diarrhea and I n wvhen nausea and vomiting preclude any oral medication. Quinidine can be administered rectally, but dosages probably two to three times those used orally may be necessary to obtain equivalent plasma concentrations.
